NEW YORK (GenomeWeb) – Qiagen has received a warning letter from the US Food and Drug Administration regarding its QuantiFeron-TB Gold blood test for tuberculosis diagnosis. The agency said there have been multiple complaints about the test's high rate of false positives and that it has been misbranded, among other violations of federal law.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.